dadstimeon Posted May 17, 2006 Share Posted May 17, 2006 http://www.upi.com/HealthBusiness/view. ... 2501-1169r MALVERN, Pa., May 17 (UPI) -- Neotropix said Wednesday the Food and Drug Administration approved a phase 1 trial of Seneca Valley Virus, a potential cancer therapy. In the phase 1 trial, Seneca Valley Virus, or SVV-001, will be administered to patients with advanced neuroendocrine cancers, including small cell lung cancer. SVV-001 is a naturally occurring virus with the ability to kill cancer cells. "Our first product may provide a breakthrough therapy for patients with some of the most serious types of cancer known, such as small cell lung cancer, for which there are few promising therapies under development," said Paul Hallenbeck, Neotropix's founder, president and chief scientific officer. "Seneca Valley Virus has the potential to be safer and more effective than treatments currently available or even on the horizon, and may help treat some of the most commonly diagnosed cancers among American men and women," Hallenbeck added. Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You can post now and register later. If you have an account, sign in now to post with your account.